Cullman Clinical Trials (Site 1140), 501 Clark St. NE. — Cullman, Alabama

Cullman Clinical Trials (Site 1140), 501 Clark St. NE. is a clinical research site located in Cullman, Alabama, United States 35055-1921.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Cullman Clinical Trials (Site 1140), 501 Clark St. NE. has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cullman Clinical Trials (Site 1140), 501 Clark St. NE.?

Cullman Clinical Trials (Site 1140), 501 Clark St. NE. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cullman Clinical Trials (Site 1140), 501 Clark St. NE. conducted?

Cullman Clinical Trials (Site 1140), 501 Clark St. NE. has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is Cullman Clinical Trials (Site 1140), 501 Clark St. NE. accredited by Crixeo Health?

Cullman Clinical Trials (Site 1140), 501 Clark St. NE. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cullman Clinical Trials (Site 1140), 501 Clark St. NE.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.